GILD
Gilead Sciences Inc. Healthcare - Biotechnology Investor Relations →
NO
50.9% ABOVE
↑ Moving away
Was 50.7% last week
Buy Threshold
$80.70
14-Week RSI
58
Advertisement
Historical Touches
GILD has crossed below its 200-week MA 15 times with an average 1-year return of +15.0% after recovery.
| Date | Weeks Below | Max Depth | 1-Year Return |
|---|---|---|---|
| Apr 2010 | 90 | -26.8% | +73.9% |
| Jul 2016 | 1 | -0.8% | -6.4% |
| Aug 2016 | 1 | -1.1% | -8.5% |
| Aug 2016 | 54 | -24.2% | -12.7% |
| Sep 2017 | 19 | -14.9% | -16.8% |
| Feb 2018 | 105 | -22.1% | +3.5% |
| Feb 2020 | 1 | -0.1% | -3.8% |
| Aug 2020 | 22 | -12.2% | +6.7% |
| Feb 2021 | 5 | -5.9% | -5.7% |
| Apr 2021 | 1 | -2.1% | -4.0% |
| Feb 2022 | 14 | -8.4% | +28.7% |
| Jun 2022 | 2 | -5.0% | +27.6% |
| Jul 2022 | 3 | -3.0% | +32.0% |
| Apr 2024 | 2 | -1.6% | +52.4% |
| May 2024 | 4 | -2.4% | +58.5% |
| Average | 21.6 | — | +15.0% |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-01-13